Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil versus placebo after curative radiotherapy for prostate cancer
ACTRN12606000116527Phase 3Active, not recruiting
- Sponsor
- William Buckland Radiotherapy Centre
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in prostate cancer (PCa) and erectile dysfunction (ED) comparing Viagra with Placebo (2 arms). Primary endpoint: Erectile function. Started Mar 2003; status: active, not recruiting.
02
Drugs
sildenafil
03
Conditions
prostate cancer (PCa)erectile dysfunction (ED)
Beyond the preview
Go deeper on ACTRN12606000116527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000116527.